Viewing StudyNCT05296525



Ignite Creation Date: 2024-05-06 @ 5:24 PM
Last Modification Date: 2024-10-26 @ 2:28 PM
Study NCT ID: NCT05296525
Status: TERMINATED
Last Update Posted: 2024-05-02
First Post: 2022-03-16

Brief Title: Evaluation of Safety and Efficacy of Allo GDA-201 NK Cells in Patients With RelapsedRefractory B Cell NHL
Sponsor: Gamida Cell ltd
Organization: Gamida Cell ltd

Conditions & Keywords Data

Conditions:
Name
Non-Hodgkin Lymphoma
Keywords:
Name View
lymphoma View
GDA-201 View
NK cells View
rituximab View
Lymphoma B-Cell View
Lymphoma Large B-Cell Diffuse View